Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of cefdinir capsule and preparation method thereof

A technology of cefdinir and dini capsules, applied in capsule delivery, pharmaceutical formulations, medical preparations of non-active ingredients, etc., to achieve the effects of improving bioavailability, taste, taste and dissolution

Active Publication Date: 2015-12-02
TIANJIN PHARMA GROUP GENCOM PHARMA
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, because cefdinir is highly stable to β-lactamase, many β-lactamase-producing microorganisms resistant to penicillins and cephalosporins are still sensitive to this product

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of cefdinir capsule and preparation method thereof
  • A kind of cefdinir capsule and preparation method thereof
  • A kind of cefdinir capsule and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0115] Formulation prescription:

[0116] Product name

Amount per capsule (mg)

[0117] Cefdinir

100

Microcrystalline cellulose

10

Lactose

10

Croscarmellose Sodium

5

Hydroxypropyl cellulose

10

Silica

5

Magnesium stearate

5

Total

145

[0118] Preparation Process:

[0119] (1) Pretreatment of raw and auxiliary materials: pass the prescribed cefdinir, microcrystalline cellulose, and lactose through a 200-mesh sieve, and mix croscarmellose sodium, hydroxypropyl cellulose and magnesium stearate through a 60-mesh sieve, The silicon dioxide is passed through a 120-mesh sieve; the raw materials of cefdinir, microcrystalline cellulose, and lactose are mixed through a 60-mesh sieve for use;

[0120] (2) Mixing: Add the resulting mixture of cefdinir, microcrystalline cellulose and lactose, together with the remaining croscarmellose sodium, hydroxypropyl cellulose, magnesium stearate, and silicon dioxide to the three-dimensional movement Mixer for 35 minutes;

[0121] (...

Embodiment 2

[0124] Formulation prescription:

[0125] Product name

Amount per capsule (mg)

Cefdinir

100

Lactose

20

Croscarmellose Sodium

5

Hydroxypropyl cellulose

10

Silica

5

Magnesium stearate

5

Total

145

[0126] Preparation Process:

[0127] (1) Pretreatment of raw and auxiliary materials: pass the prescribed cefdinir and lactose through a 200-mesh sieve, croscarmellose sodium, hydroxypropyl cellulose, and magnesium stearate are mixed through a 60-mesh sieve, and the silicon dioxide is passed through 120 Mesh sieve; mix cefdinir raw material and lactose through a 60-mesh sieve, set aside;

[0128] (2) Mixing: Add the obtained mixture of cefdinir and lactose, together with the remaining croscarmellose sodium, hydroxypropyl cellulose, magnesium stearate, and silicon dioxide, to the three-dimensional motion mixer and mix for 40 minutes ;

[0129] (3) Filling: add the evenly mixed powder to the filling machine, control the vacuum pressure -0.02~-0.06MPa, the distance between...

Embodiment 3

[0132] Formulation prescription:

[0133] Product name

Amount per capsule (mg)

Cefdinir

100

Lactose

20

Hydroxypropyl cellulose

15

Silica

5

Magnesium stearate

5

Total

145

[0134] Preparation Process:

[0135] (1) Pretreatment of raw and auxiliary materials: pass the prescribed cefdinir and lactose through a 200-mesh sieve, hydroxypropyl cellulose and magnesium stearate are mixed through a 60-mesh sieve, and silicon dioxide is passed through a 120-mesh sieve; Mix lactose through a 60-mesh sieve and set aside;

[0136] (2) Mixing: add the resulting mixture of cefdinir and lactose, together with the remaining hydroxypropyl cellulose, magnesium stearate, and silicon dioxide, to the three-dimensional motion mixer and mix for 45 minutes;

[0137] (3) Filling: add the evenly mixed powder to the filling machine, control the vacuum pressure -0.02~-0.06MPa, the distance between the measuring discs is 0.04~1mm; the filling speed is 1200~1300 grains / min, and the medicine column...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a preparation of a cefdinir capsule and a preparation method thereof. The cefdinir capsule comprises the following components in parts by weight: 90 to 110 parts of cefdinir, 15 to 25 parts of filling agent, 10 to 15 parts of disintegrating agent, 1 to 5 parts of disintegrating accelerant and 1 to 5 parts of other auxiliary materials. The preparation method comprises the following steps: (1) pretreatment of raw auxiliary materials; (2) mixing; (3) filling; and (4) blister packaging.

Description

Technical field [0001] The invention belongs to the field of pharmaceutical preparations. Specifically, the invention relates to a cefdinir capsule and a preparation method thereof. Background technique [0002] Cefdinir is the third-generation oral broad-spectrum cephalosporin, which belongs to the β-lactam antibiotic. It was developed by Fujisawa Corporation of Japan. It was first marketed in Japan in 1991. The brand name is Cefzon and the chemical name is (6R, 7R)- 7-[2-(2-Amino-4thiazolyl)-(oximino)acetyl]amino]-3-vinyl-8oxo-5-thia-1-azabicyclo[4,2,0 ]Oct-2-ene-2-carboxylic acid, with the structure of formula I: [0003] [0004] Cefdinir is absorbed through the intestinal tract after oral administration, which can inhibit bacterial cell wall synthesis and produce antibacterial effects. Cefdinir's antibacterial spectrum includes Staphylococcus aureus, Streptococcus, Gram-positive bacteria and Gram-negative bacteria. It is clinically mainly used to treat mild to moderate infec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/48A61K31/546A61K47/26A61P31/04
Inventor 姜起栋万军李纯钢肖圣红黄薇芮庆云张齐魏晨曦刘洪涛
Owner TIANJIN PHARMA GROUP GENCOM PHARMA